Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Helicobacter Pylori | Research article

Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review

Authors: Yingying Mao, Wenjun Yang, Qi Qi, Fei Yu, Tianpei Wang, Hongfei Zhang, Juncheng Dai, Hongxia Ma, Zhibin Hu, Hongbing Shen, Gang Li, Guangfu Jin

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

The association of ABO blood groups with gastric cancer risk was proposed decades ago, but the results have been inconsistent.

Methods

We used two single nucleotide polymorphisms to determine ABO genotype in 4932 gastric cancer cases and 6158 controls of Chinese descent, and evaluated the associations of ABO blood groups and genotypes with risk of gastric cancer using multivariable logistic regression models. We also systematically reviewed published literature and performed a meta-analysis of all relevant studies.

Results

In the case-control study, compared with blood group O, both blood group A and AB were associated with increased gastric cancer risk (for group A, odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.02–1.24; for group AB, OR = 1.18, 95% CI: 1.02–1.36, respectively). Analyses of ABO genotypes revealed associations of AO and AB with risk of gastric cancer compared with OO genotype. Consistent with the case-control study, meta-analysis of 40 studies including 33,613 cases and 2,431,327 controls demonstrated that blood group A (OR = 1.19, 95% CI: 1.13–1.25) and AB (OR = 1.09, 95% CI: 1.03–1.16) were associated with increased risk of gastric cancer.

Conclusions

Our analyses validated the association of blood group A with risk of gastric cancer, and suggested that blood group AB was also associated with gastric cancer risk. Functional investigations are warranted to elucidate the exact mechanism of ABO blood groups in gastric carcinogenesis.
Appendix
Available only for authorised users
Literature
1.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRef
2.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRef
3.
Amieva M, Peek RM, Jr.: Pathobiology of helicobacter pylori-induced gastric Cancer. Gastroenterology 2016, 150(1):64–78.
4.
Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N: Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control : CCC 2008, 19(7):689–701.
5.
Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P. A meta-analysis on alcohol drinking and gastric cancer risk. Annals of oncology : official journal of the European Society for Med Oncol. 2012;23(1):28–36.CrossRef
6.
D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489–98.CrossRef
7.
Lesky E. Viennese serological research about the year 1900: its contribution to the development of clinical medicine. Bull N Y Acad Med. 1973;49(2):100–11.PubMedPubMedCentral
8.
Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1(4814):799–801.CrossRef
9.
Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, Wang M, Miao X, Zhou Y, Lu F, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43(12):1215–8.CrossRef
10.
Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42(9):764–7.CrossRef
11.
Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, Brennan P, Bueno-de-Mesquita HB, Gapstur SM, Giovannucci E, et al. ABO blood group alleles and prostate cancer risk: results from the breast and prostate cancer cohort consortium (BPC3). Prostate. 2015;75(15):1677–81.CrossRef
12.
Patnaik SK, Helmberg W, Blumenfeld OO. BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res. 2012;40(Database issue):D1023–9.CrossRef
13.
Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698–709.CrossRef
14.
Mentis A, Lehours P, Megraud F. Epidemiology and diagnosis of helicobacter pylori infection. Helicobacter. 2015;(20 Suppl):1:1–7.
15.
Oh S, Kim N, Kwon JW, Shin CM, Choi YJ, Lee DH, Jung HC. Effect of helicobacter pylori eradication and ABO genotype on gastric Cancer development. Helicobacter. 2016.
16.
Song HR, Shin MH, Kim HN, Piao JM, Choi JS, Hwang JE, Park YK, Ryang DW, Cho D, Kweon SS. Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2013;16(2):254–60.CrossRef
17.
Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, Ito S, Sawaki A, Iida S, Sato S et al: ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011, 20(8):1665–1672.
18.
Li B, Tan B, Chen C, Zhao L, Qin L. Association between the ABO blood group and risk of common cancers. J evidence-based medicine. 2014;7(2):79–83.CrossRef
19.
Wang Z, Liu L, Ji J, Zhang J, Yan M, Zhang J, Liu B, Zhu Z, Yu Y. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci. 2012;13(10):13308–21.CrossRef
20.
Gong Y, Yang YS, Zhang XM, Su M, Wang J, Han JD, Guo MZ. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China. World J Gastroenterol. 2012;18(6):563–9.CrossRef
21.
Qiu MZ, Zhang DS, Ruan DY, Luo HY, Wang ZQ, Zhou ZW, Wang FH, Li YH, Xu RH: A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China. Med Oncol 2011, 28 Suppl 1:S268–273.
22.
Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer. 2010;46(18):3345–50.CrossRef
23.
El H II, Hashash JG, Baz EM, Abdul-Baki H, Sharara AI. ABO blood group and gastric cancer: rekindling an old fire? South Med J. 2007;100(7):726–7.CrossRef
24.
Sharara AI, Abdul-Baki H, ElHajj I, Kreidieh N, Kfoury Baz EM. Association of gastroduodenal disease phenotype with ABO blood group and helicobacter pylori virulence-specific serotypes. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2006;38(11):829–33.CrossRef
25.
Zivanovic-Posilovic G, Milicic J, Bozicevic D. Dermatoglyphs and gastric cancer. Collegium antropologicum. 2003;27(1):213–9.PubMed
26.
Su M, Lu SM, Tian DP, Zhao H, Li XY, Li DR, Zheng ZC. Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol. 2001;7(5):657–61.CrossRef
27.
Klaamas K, Kurtenkov O, Covacci A, Lipping A, Wadstrom T. Immune response to a recombinant fragment of the CagA protein of helicobacter pylori in blood donors and patients with gastric cancer: relation to ABO(H) blood group phenotype, stage of the disease and tumor morphology. Med Microbiol Immunol. 1999;187(4):227–32.CrossRef
28.
Glober GA, Cantrell EG, Doll R, Peto R. Interaction between ABO and rhesus blood groups, the site of origin of gastric cancers, and the age and sex of the patient. Gut. 1971;12(7):570–3.CrossRef
29.
Hoskins LC, Loux HA, Britten A, Zamcheck N. Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with pernicious anemia. N Engl J Med. 1965;273(12):633–7.CrossRef
30.
Hartmann O, Stavem P. Abo blood-groups and Cancer. Lancet. 1964;1(7346):1305–6.CrossRef
31.
Lisker R, Taboada C, Reyes JL. Distribution of the abo blood groups in peptic ulcer, gastric carcinoma and liver cirrhosis in a Mexican population. Vox Sang. 1964;9:202–3.CrossRef
32.
Jayant K. Relationship of ABO blood groups to certain types of cancer common in Western India. Indian J Cancer. 1971;8(3):185–8.PubMed
33.
Duell EJ, Bonet C, Munoz X, Lujan-Barroso L, Weiderpass E, Boutron-Ruault MC, Racine A, Severi G, Canzian F, Rizzato C, et al. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int J Cancer. 2015;136(4):880–93.CrossRef
34.
Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative helicobacter pylori infection. Gut. 1997;40(3):297–301.CrossRef
35.
Hsiao LT, Liu NJ, You SL, Hwang LC. ABO blood group and the risk of cancer among middle-aged people in Taiwan. Asia-Pacific journal of clinical oncology. 2015;11(4):e31–6.CrossRef
36.
Sun W, Wen CP, Lin J, Wen C, Pu X, Huang M, Tsai MK, Tsao CK, Wu X, Chow WH. ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol. 2015;39(2):150–6.CrossRef
37.
Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, Nyren O. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280–5.CrossRef
38.
Etemadi A, Kamangar F, Islami F, Poustchi H, Pourshams A, Brennan P, Boffetta P, Malekzadeh R, Dawsey SM, Abnet CC, et al. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan cohort study. BMC Med. 2015;13:8.CrossRef
39.
Sievers ML. Hereditary aspects of gastric secretory function; race and ABO blood groups in relationship to acid and pepsin production. Am J Med. 1959;27:246–55.CrossRef
40.
Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, Miletich JP, Ridker PM. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4(7):e1000118.CrossRef
41.
Aguiar DC, Corvelo TC, Ara jo M, Cruz EM, Daibes S, Assumpcao MB. Expression of ABH and Lewis antigens in chronic gastritis and pre-neoplasic alterations in gastric mucosa. Arq Gastroenterol. 2002;39(4):222–32.CrossRef
42.
Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, et al. Identification of genetic loci associated with helicobacter pylori serologic status. Jama. 2013;309(18):1912–20.CrossRef
Metadata
Title
Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review
Authors
Yingying Mao
Wenjun Yang
Qi Qi
Fei Yu
Tianpei Wang
Hongfei Zhang
Juncheng Dai
Hongxia Ma
Zhibin Hu
Hongbing Shen
Gang Li
Guangfu Jin
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5355-4

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue

Research article

Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p

Research article

Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery

Research article

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines

Research article

Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma

Research article

Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study

Study protocol

Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits